|
Volumn 37, Issue 5, 2007, Pages 1161-1164
|
NK cells - From basic research to cancer therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERLEUKIN 15;
INTERLEUKIN 2;
KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN;
KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
NATURAL KILLER CELL RECEPTOR;
NATURAL KILLER CELL RECEPTOR NKG2D;
RITUXIMAB;
ACUTE GRAFT VERSUS HOST DISEASE;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADOPTIVE IMMUNOTHERAPY;
ALLOIMMUNITY;
BONE MARROW TRANSPLANTATION;
CANCER IMMUNOTHERAPY;
CELL INTERACTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;
HLA MATCHING;
HUMAN;
IMMUNE RESPONSE;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE ACTIVATION;
MACROPHAGE ACTIVATION;
NATURAL KILLER CELL;
NATURAL KILLER CELL MEDIATED CYTOTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
T CELL DEPLETION;
ANIMALS;
HUMANS;
IMMUNOTHERAPY;
KILLER CELLS, NATURAL;
NEOPLASMS;
|
EID: 34250311204
PISSN: 00142980
EISSN: None
Source Type: Journal
DOI: 10.1002/eji.200790017 Document Type: Conference Paper |
Times cited : (6)
|
References (20)
|